Treatment of Neovascular Age Related Macular Degeneration

QR Code

Treatment of Neovascular Age Related Macular Degeneration

None

Saved in:

Bibliographic Details
Main Authors:	Lazić, Ratimir, Gabric, Nikica
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26334
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Experimental Treatments for Neovascular Age-Related Macular Degeneration
by: Regatieri, C. V., et al.
Published: (2012)

Regulation of Angiogenesis in Choroidal Neovascularization of Age Related Macular Degeneration by Endogenous Angioinhibitors
by: Gunda, Venugopal, et al.
Published: (2012)

Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01)

Wet Age Related Macular Degeneration
by: Afshari, Fardad, et al.
Published: (2012)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Principles of anti-VEGF dosing in the treatment of neovascular age-related macular degeneration
by: I. E. Ioshin, et al.
Published: (2019-08-01)

Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01)

Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration
by: F. A. Bakhritdinova, et al.
Published: (2018-10-01)

Evaluation of the efficacy of surgical treatment of cataracts in patients with neovascular age-related macular degeneration
by: A. Zh. Fursova, et al.
Published: (2024-12-01)

Clinical, functional and aberrometric parallels in the treatment of the neovascular form of age-related macular degeneration
by: M. M. Magomedova, et al.
Published: (2024-07-01)

Nutritional Supplement Use and Age-Related Macular Degeneration
by: Lo, Amy C. Y., et al.
Published: (2012)

Clinical Phenotypes of Patients with Neovascular Age-Related Macular Degeneration and Poor Response to Aflibercept Treatment
by: V. G. Likhvantseva, et al.
Published: (2022-10-01)

Obesity as a Risk Factor for the Ineffectiveness of Antiangiogenic Treatment of Neovascular Age-related Macular Degeneration
by: V. G. Likhvantseva, et al.
Published: (2024-04-01)

Real-world outcomes and treatment patterns in Colombian patients with neovascular age-related macular degeneration and diabetic macular edema
by: Joshua Kock, et al.
Published: (2025-06-01)

Risk Factor of Neovascular Agerelated Macular Degeneration Progression after Cataract Surgery
by: V. G. Likhvantseva, et al.
Published: (2024-04-01)

Pathogenic Roles of Sterile Inflammation in Etiology of Age-Related Macular Degeneration
by: Qin, Suofu
Published: (2012)

Use of OCT Imaging in the Diagnosis and Monitoring of Age Related Macular Degeneration
by: Ţălu, Simona-Delia, et al.
Published: (2012)

Basic Research and Clinical Application of Drug Delivery Systems for the Treatment of Age-Related Macular Degeneration
by: Giudice, Giuseppe Lo, et al.
Published: (2012)

Non-Enzymatic Post-Translational Modifications in the Development of Age-Related Macular Degeneration
by: Kaji, Yuichi, et al.
Published: (2012)

Efficacy of aflibercept in patients with neovascular age-related macular degeneration when combined with cataract surgery
by: A. A. Kuznetsov, et al.
Published: (2018-10-01)

Choroidal neovascularization activity and structure by optical coherence tomography angiography in age related macular degeneration
by: M. A. Kovalevskaya, et al.
Published: (2021-12-01)

Quantitative characterization of types 1 and 2 macular neovascularization in neovascular age-related macular degeneration with intravitreal conbercept: an analysis utilizing optical coherence tomography angiography
by: Yan-Mei Shi, et al.
Published: (2025-08-01)

Preferences of Hospital Pharmacists for the Different Attributes of Intravitreal Treatments for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Spain: The SEEKING Study
by: José Luis Poveda, et al.
Published: (2025-05-01)

Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)

Study of the Level of Pro- and Antiangiogenic Growth Factors in Vitreous Fluid in Neovascular Age-Related Macular Degeneration on the Background of Treatment
by: M. M. Arkhipova, et al.
Published: (2022-07-01)

Optical coherence tomography angiography for choroidal neovascularization in pathological myopia and neovascular age-related macular degeneration in combination with axial myopia in comparative analysis
by: E. A. Drozdova, et al.
Published: (2021-12-01)

Two-Photon Excitation Photodynamic Therapy: Working Toward a New Treatment for Wet Age-Related Macular Degeneration
by: Probodh, Ira, et al.
Published: (2012)

The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical study
by: V. V. Neroev, et al.
Published: (2023-12-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Treatment as Required versus Regular Monthly Treatment in the Management of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.
by: Christine M Schmucker, et al.
Published: (2015-01-01)

Safety and effectiveness of brolucizumab in patients with neovascular age-related macular degeneration: A phase IV study from India
by: Asim K Ghosh, et al.
Published: (2025-06-01)

Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom
by: Muiz Musadiq, et al.
Published: (2025-06-01)

RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration
by: Zhou J, et al.
Published: (2025-06-01)

Short-term Outcomes of Anti-VEGF therapy in Neovascular Age-related Macular Degeneration with Initially Low Visual Acuity
by: A. N. Kulikov, et al.
Published: (2025-03-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

Comprehensive evaluation of cataract phacoemulsification surgery efficacy in patients with neovascular age-related macular degeneration treated by of antiangiogenic drugs
by: A. Zh. Fursova, et al.
Published: (2025-07-01)

Bruch’s Membrane: The Critical Boundary in Macular Degeneration
by: Mullins, Robert F., et al.
Published: (2012)

Experiences of treatment of age related macular degeneration with concomitant myopia
by: I. B. Alekseev, et al.
Published: (2019-03-01)